DAL-1 attenuates epithelial to mesenchymal transition and metastasis by suppressing HSPA5 expression in non-small cell lung cancer.

Abstract:

:Metastasis is the primary cause of death in lung cancer patients and EMT (epithelial-mesenchymal transition) promotes metastasis. Previous study revealed that DAL-1 (differentially expressed in adenocarcinoma of the lung) could attenuate EMT and metastasis in non-small cell lung cancer (NSCLC). Further study proved that HSPA5 (heat shock protein 5), which has a promoting effect on EMT, could bind to DAL-1. In this study, the mRNA and protein expression levels of target molecules were detected by RTq-PCR and western blot assays, the migration and invasion abilities were examined by Transwell migration and invasion assay, and the proliferation ability was measured by CCK-8 assay. We revealed that DAL-1 was downregulated while HSPA5 was upregulated in NSCLC and found the protein of DAL-1 and HSPA5 co-localized in the cytoplasm and nucleus. We demonstrated that DAL-1 can suppress the expression of HSPA5 on mRNA and protein levels, and decrease EMT, migration, invasion and proliferation abilities by down-regulating HSPA5. Furthermore, we discovered that DAL-1 plays a role in inhibiting PI3K/Akt/Mdm2 signaling pathway by suppressing HSPA5.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Qiu X,Guan X,Liu W,Zhang Y

doi

10.3892/or.2017.6000

subject

Has Abstract

pub_date

2017-11-01 00:00:00

pages

3103-3113

issue

5

eissn

1021-335X

issn

1791-2431

journal_volume

38

pub_type

杂志文章
  • Overexpression of IC53d promotes the proliferation of gastric cancer cells by activating the AKT/GSK3β/cyclin D1 signaling pathway.

    abstract::Cyclin‑dependent kinase 5 regulatory subunit‑​associated protein 3 (CDK5RAP3 or C53) is involved in the development of various types of tumor, and alternative splicing of C53 results in numerous transcription variants that encode different isoforms. The present study aimed to clone human C53 isoform d (IC53d) and expl...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7042

    authors: Lin JX,Xie XS,Weng XF,Qiu SL,Xie JW,Wang JB,Lu J,Chen QY,Cao LL,Lin M,Tu RH,Li P,Huang CM,Zheng CH

    更新日期:2019-05-01 00:00:00

  • Paeonol exerts an anticancer effect on human colorectal cancer cells through inhibition of PGE₂ synthesis and COX-2 expression.

    abstract::Cyclooxygenase-2 (COX-2) and its metabolite prostaglandin E2 (PGE2) can potentially affect most of the events in cancer development, including promotion of proliferation, resistance to apoptosis, angiogenesis, immune suppression and invasion. However, worldwide attention has predominantly centered on the cardiovascula...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3543

    authors: Li M,Tan SY,Wang XF

    更新日期:2014-12-01 00:00:00

  • Predicting the tumor response to radiotherapy using microarray analysis (Review).

    abstract::Predicting the tumor response to radiotherapy is one of the major goals of human cancer treatment. Identification of the genes that are differentially expressed between radiosensitive and radioresistant cancers by global gene analysis may provide new insights into the mechanisms underlying clinical radioresistance and...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:

    authors: Ogawa K,Murayama S,Mori M

    更新日期:2007-11-01 00:00:00

  • Evaluation of the novel gene Rabl3 in the regulation of proliferation and motility in human cancer cells.

    abstract::Rab is a large subfamily of small GTPases which play an important role in multiple processes relating to cellular transportation and modulation of the cytoskeleton. Novel gene Rab-like 3 (Rabl3), which we originally reported as a new member belonging to this subfamily, may participate in other processes in human cance...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000876

    authors: Li Q,Wang L,Zeng L,Zhang Y,Li K,Jin P,Su B,Wang L

    更新日期:2010-08-01 00:00:00

  • In silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme.

    abstract::MicroRNAs (miRNAs or miRs) contribute to the development of various malignant neoplasms, including glioblastoma multiforme (GBM). The present study aimed to explore the pathogenesis of GBM and to identify latent therapeutic agents for patients with GBM, based on an in silico analysis. Gene chips that provide miRNA exp...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7022

    authors: Xiong DD,Xu WQ,He RQ,Dang YW,Chen G,Luo DZ

    更新日期:2019-04-01 00:00:00

  • Silencing of argininosuccinate lyase inhibits colorectal cancer formation.

    abstract::Arginine and nitric oxide (NO) are important mediators of tumorigenesis in various types of cancer. Dysregulation of NO content by argininosuccinate lyase (ASL) has been previously demonstrated to inhibit the proliferation of liver and breast cancer cells. However, the function of ASL in colon cancer is not well defin...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5221

    authors: Huang HL,Chen WC,Hsu HP,Cho CY,Hung YH,Wang CY,Lai MD

    更新日期:2017-01-01 00:00:00

  • IL22 furthers malignant transformation of rat mesenchymal stem cells, possibly in association with IL22RA1/STAT3 signaling.

    abstract::Mesenchymal stem cells (MSCs) hold great promise as potential therapies for tumors through the delivery of various anticancer agents. However, exogenous tissue‑derived MSCs, such as those of bone marrow, have exhibited a tendency for malignant transformation in the tumor microenvironment. This issue remains controvers...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7007

    authors: Cui X,Jing X,Yi Q,Xiang Z,Tian J,Tan B,Zhu J

    更新日期:2019-04-01 00:00:00

  • HOXB13-mediated suppression of p21WAF1/CIP1 regulates JNK/c-Jun signaling in prostate cancer cells.

    abstract::Many prostate cancer (PCa) patients die of recurrent disease due to the emergence of hormone-independent cancer cells of which the mechanism is not fully understood. Our previous studies demonstrated that most castration- resistant prostate cancers (CRPC) overexpress the HOXB13 transcription factor to confer positive ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4563

    authors: Kim YR,Kang TW,To PK,Xuan Nguyen NT,Cho YS,Jung C,Kim MS

    更新日期:2016-04-01 00:00:00

  • Histological features of extratumoral breast lesions as a predictive factor of familial breast cancer.

    abstract::The aim of this study was to verify whether histopathological features of extratumoral and of primary tumor breast tissue could play a role in identifying patients with familial characteristics. We examined the clinicopathological features of 504 patients with sporadic or familial breast cancer stratified for risk of ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000806

    authors: Mangia A,Tommasi S,Bruno M,Malfettone A,D'Amico C,Zito FA,Paradiso A,Simone G

    更新日期:2010-06-01 00:00:00

  • Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma.

    abstract::Hypoxia promotes the invasive and metastatic potential of tumour cells. A recent study has shown that the activation of the chemokine receptor CXCR4 by lack of oxygen in breast cancer is HIF-1-dependent. We have previously demonstrated that CXCR4 signalling is involved in the establishment of lymph node metastasis in ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Ishikawa T,Nakashiro K,Klosek SK,Goda H,Hara S,Uchida D,Hamakawa H

    更新日期:2009-03-01 00:00:00

  • Novel EXT1 mutation identified in a pedigree with hereditary multiple exostoses.

    abstract::Hereditary multiple exostoses (HME) is an autosomal dominant bone disorder characterized by the presence of multiple benign cartilage-capped tumors. EXT1 located on chromosome 8q23-q24 and EXT2 located on 11p11-p12 are the main disease-causing genes which are responsible for ~90% of HME cases. Mutations of EXT1 or EXT...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2891

    authors: Cao L,Liu F,Kong M,Fang Y,Gu H,Chen Y,Zhao C,Zhang S,Bi Q

    更新日期:2014-02-01 00:00:00

  • Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler.

    abstract::Activating mutations of Ras gene families have been found in a variety of human malignancies, including lung cancer, suggesting their dominant role in tumorigenesis. Many studies have showed that the Kras gene is activated by point mutations in approximately 15-20% of non-small cell lung cancers (NSCLCs), however, the...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Sasaki H,Okuda K,Kawano O,Endo K,Yukiue H,Yokoyama T,Yano M,Fujii Y

    更新日期:2007-09-01 00:00:00

  • Metabolism of irinotecan and its active metabolite SN-38 by intestinal microflora in rats.

    abstract::One of the dose-limiting toxicities of irinotecan (CPT-11) is delayed-onset diarrhea, which is the greatest barrier to treatment with CPT-11-containing regimens. CPT-11 is converted to its active metabolite, SN-38, which is conjugated by hepatic uridine diphosphate glucuronosyl transferase to SN-38 glucuronide (SN-38G...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Yamamoto M,Kurita A,Asahara T,Takakura A,Katono K,Iwasaki M,Ryuge S,Wada M,Onoda S,Yanaihara T,Yokoba M,Mitsufuji H,Nishii Y,Fukui T,Masuda N

    更新日期:2008-10-01 00:00:00

  • 18F-fluorothymidine PET/CT as an early predictor of tumor response to treatment with cetuximab in human lung cancer xenografts.

    abstract::We investigated whether 18F-fluorothymidine-positron-emission tomography/computed tomography (18F-FLT-PET/CT) is useful for the evaluation of the very early response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab therapy in human lung cancer xenografts. A human tumor xenograft model was established...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1338

    authors: Takeuchi S,Zhao S,Kuge Y,Zhao Y,Nishijima K,Hatano T,Shimizu Y,Kinoshita I,Tamaki N,Dosaka-Akita H

    更新日期:2011-09-01 00:00:00

  • Expression of transglutaminases in human breast cancer and their possible clinical significance.

    abstract::Implicated in several physiologic processes, including tumour-host, some transglutaminases (TGase) have been noted to play a regulatory role in the extracellular matrix in cell adhesion and migration of cancer cells. This study sought to determine the level of expression of TGases and their possible clinical significa...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Jiang WG,Ablin R,Douglas-Jones A,Mansel RE

    更新日期:2003-11-01 00:00:00

  • Honokiol exhibits enhanced antitumor effects with chloroquine by inducing cell death and inhibiting autophagy in human non-small cell lung cancer cells.

    abstract::Honokiol (HNK), a potential antitumor compound, has been widely studied in recent years. It induces apoptosis and affects autophagy in cancer cells, yet the mechanism of its antitumor efficacy remains obscure. Chloroquine (CQ), an autophagy inhibitor, is often applied to sensitize antitumor drugs in clinical trials. H...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4091

    authors: Lv X,Liu F,Shang Y,Chen SZ

    更新日期:2015-09-01 00:00:00

  • Immunotherapy for Lewis lung carcinoma utilizing dendritic cells infected with CK19 gene recombinant adenoviral vectors.

    abstract::Dendritic cells (DCs) as 'professional' antigen-presenting cells (APCs) initiate and regulate immune responses to various antigens. DC-based vaccines have become a promising modality in cancer immunotherapy. Cytokeratin 19 (CK19) protein is expressed at high levels in lung cancer and many other tumor cells, suggesting...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4231

    authors: Sun QF,Zhao XN,Peng CL,Hao YT,Zhao YP,Jiang N,Xue H,Guo JZ,Yun CH,Cong B,Zhao XG

    更新日期:2015-11-01 00:00:00

  • Treatment of (131)I-labeled anti-CD147 monoclonal antibody in VX2 carcinoma-induced liver tumors.

    abstract::Hepatocellular carcinoma (HCC) is a major health problem worldwide. CD147 has been reported to be overexpressed in HCC and blocking CD147 expression can decrease tumor growth. (131)I is often used in combination with other drugs to treat HCC and yields positive results. In this study, we combined the (131)I and CD147 ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2418

    authors: Niu H,Wang R,Cheng J,Gao S,Liu B

    更新日期:2013-07-01 00:00:00

  • A study on anti-tumor immunity induced by gene-modified melanoma B16 cells.

    abstract::T cell-mediated cell immunity is the main anti-tumor immunity in which the effector T cells need specific antigen and costimulatory signals. One of the vaccines applied in tumor immunotherapy is the gene-modified tumor cell vaccine. One potential method to increase cell epitope density is to link the antigen with the ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Fang L,Wang K,Liu X,Zhang L,Zhang X,Qian L,Lu J,Qian G,Ge S

    更新日期:2008-06-01 00:00:00

  • ERAP140/Nbla10993 is a novel favorable prognostic indicator for neuroblastoma induced in response to retinoic acid.

    abstract::In the present study, we identified a gene termed Nbla10993 whose expression levels are higher in favorable neuroblastomas versus unfavorable ones. Structural analysis showed that Nbla10993 is a novel splicing variant of the ER-associated protein of 140 kDa (ERAP140), which lacks the central acidic as well as the COOH...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Arai H,Ozaki T,Niizuma H,Nakamura Y,Ohira M,Takano K,Matsumoto M,Nakagawara A

    更新日期:2008-06-01 00:00:00

  • Carbon ions and X‑rays induce pro‑inflammatory effects in 3D oral mucosa models with and without PBMCs.

    abstract::Oral mucositis is a severe complication of radiotherapy. Hence, it may constitute a serious medical safety risk for astronauts during extended space flights, such as missions to Mars, during which they are exposed to heavy-ion irradiation. For risk assessment of developing radiation-induced mucositis, a three-dimensio...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3441

    authors: Tschachojan V,Schroer H,Averbeck N,Mueller-Klieser W

    更新日期:2014-11-01 00:00:00

  • An increase in the percentage of HLA-DR-positive peripheral leukocytes predicts a poor prognosis in patients with squamous cell carcinoma of the lung.

    abstract::Immunologic factors that predict survival in patients with lung cancer have not been established. We examined the relationship between the percentage of HLA-DR-positive peripheral leukocytes [HLA-DR+ (%)] and survival of patients with squamous cell carcinoma of the lung. Before initiating therapy, peripheral blood was...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Nakamura H,Idiris A,Kato Y,Kato H

    更新日期:2004-03-01 00:00:00

  • Rejection of adenovirus infection is independent of coxsackie and adenovirus receptor expression in cisplatin-resistant human lung cancer cells.

    abstract::The adenovirus vector-based cancer gene therapy is controversial. Low transduction efficacy is believed to be one of the main barriers for the decreased expression of coxsackie and adenovirus receptor (CAR) on tumor cells. However, the expression of CAR on primary tumor tissue and tumor tissue survived from treatment ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4870

    authors: Zhang NH,Peng RQ,Ding Y,Zhang XS

    更新日期:2016-08-01 00:00:00

  • Investigating the relationship between serum thrombopoietin kinetics and the platelet-sparing effect: A clinical pharmacological evaluation of combined paclitaxel and carboplatin in patients with non-small cell lung cancer.

    abstract::We conducted a clinical pharmacological evaluation of paclitaxel/carboplatin combination in Japanese patients with non-small cell lung cancer. The purpose of this study was to identify the optimal dose of this combination and to investigate the relationships between the pharmacokinetic profiles of these 2 drugs, serum...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Daga H,Isobe T,Miyazaki M,Fujitaka K,Kondo K,Kohno N

    更新日期:2004-06-01 00:00:00

  • Involvement of ROS in the inhibitory effect of thermotherapy combined with chemotherapy on A549 human lung adenocarcinoma cell growth through the Akt pathway.

    abstract::Mechanisms of synergistic effect of thermotherapy and chemotherapy on human lung adenocarcinoma cell growth are unclear. The purpose of this study was to investigate these effects and explore the function of ROS, Akt and caspase-3 in relation to these. A549 cells were subjected to different thermochemotherapy treatmen...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1954

    authors: Wang L,Liu X,Wu Y,Wu W,Wu Y

    更新日期:2012-10-01 00:00:00

  • Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway.

    abstract::Acute lymphoblastic leukemia (ALL) is a malignant hematological disease. Tanshinone IIA (Tan IIA) has antitumor activity in vitro and in vivo. The aim of the present study was to investigate the effects of Tan IIA in combination with imatinib (IM) on the proliferation, apoptosis, migration and invasion of acute T lymp...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7453

    authors: Teng Z,Xu S,Lei Q

    更新日期:2020-02-01 00:00:00

  • Association of FOSB exon 4 unmethylation with poor prognosis in patients with late‑stage non‑small cell lung cancer.

    abstract::Alterations in DNA methylation have a central role in the development and outcome of most human malignancies. Non‑small cell lung cancer (NSCLC), the most common lung cancer, leads to the largest number of cancer‑related deaths worldwide. FBJ murine osteosarcoma viral oncogene homolog B (FOSB) is a key component of th...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7431

    authors: Kim DS,Lee WK,Park JY

    更新日期:2020-02-01 00:00:00

  • Oxymatrine inhibits epithelial-mesenchymal transition through regulation of NF-κB signaling in colorectal cancer cells.

    abstract::Oxymatrine, a traditional Chinese herb extracted from Sophora flavescens Ait., displays strong anti-inflammatory and anticancer activities, but how oxymatrine exhibits anticarcinogenic effects in human colorectal cancer (CRC) remains uncertain. The present study aimed to elucidate the exact mechanism by which oxymatri...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4927

    authors: Liang L,Huang J

    更新日期:2016-09-01 00:00:00

  • Antiangiogenic agent, thalidomide increases the antitumor effect of single high dose irradiation (gamma knife radiosurgery) in the rat orthotopic glioma model.

    abstract::Gliomas are primary brain tumors associated with a poor prognosis partly due to resistance to conventional therapies. To overcome this problem, we investigated the combined effects of gamma knife radiosurgery (GKS) and an antiangiogenic agent, thalidomide (THD), or a chemotherapeutic agent, temozolomide (TMZ), on a ra...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Lee JI,Itasaka S,Kim JT,Nam DH

    更新日期:2006-05-01 00:00:00

  • The expression of high-mobility group protein box 1 correlates with the progression of non-small cell lung cancer.

    abstract::High-mobility group protein box 1 (HMGB1) released from dying tumor cells promotes tumor progression, on the other hand HMGB1 activates dendritic cells and triggers anti-neoplastic response of T-cells in chemotherapy and radiotherapy. HMGB1 expression is up-regulated in many kinds of tumors. To investigate HMGB1 expre...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000468

    authors: Shen X,Hong L,Sun H,Shi M,Song Y

    更新日期:2009-09-01 00:00:00